Clinical efficacy of recombinant human epidermal growth factor solution in relieving pharyngeal pain after Viral cold
Global Insights in Medicine and Nursing · 25.03.2026 · 2 (1) · 1-6
DOI: 10.65140/gimn202602.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Insights in Medicine and Nursing, online erschienen am 25.03.2026. Verfasst von Zhonghua Wu und 3 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This study aimed to evaluate how well recombinant human epidermal growth factor (rhEGF) works in relieving throat pain caused by a viral cold.
Methods
Fifty patients aged 18–70 years with mild Omicron variant SARS-CoV-2 infection, no underlying diseases, and sore throat symptoms were enrolled. They were randomly assigned to either a control group (conventional therapy) or an EGF treatment group (conventional therapy plus EGF spray). The visual analog scale (VAS) score for pain, time to onset of pain relief, duration of analgesic effect, and recovery of the posterior pharyngeal wall mucosa were compared between the two groups before and after treatment.
Results
Compared with the control group, the EGF treatment group showed a significantly shorter time to pain relief, longer duration of effect, and better mucosal recovery of the posterior pharyngeal wall, with statistically significant differences.
Conclusion
Topical application of recombinant human epidermal growth factor can effectively and rapidly relieve pain caused by viral pharyngitis and promote mucosal repair, demonstrating a favorable adjuvant role in the treatment of viral cold accompanied by inflammatory pharyngeal pain.
Zitieren
APA
Wu, Z., Chen, D., Liu, J., & Wang, X. (2026). Clinical efficacy of recombinant human epidermal growth factor solution in relieving pharyngeal pain after Viral cold. Global Insights in Medicine and Nursing, 2(1), 1-6. https://doi.org/10.65140/gimn202602.11
Vancouver
Wu Z, Chen D, Liu J, Wang X. Clinical efficacy of recombinant human epidermal growth factor solution in relieving pharyngeal pain after Viral cold. Global Insights in Medicine and Nursing. 2026;2(1):1-6. doi:10.65140/gimn202602.11
BibTeX
@article{Wu2026,
author = {Wu, Zhonghua and Chen, Dongsheng and Liu, Junlin and Wang, Xin},
title = {Clinical efficacy of recombinant human epidermal growth factor solution in relieving pharyngeal pain after Viral cold},
journal = {Global Insights in Medicine and Nursing},
year = {2026},
volume = {2},
number = {1},
pages = {1--6},
doi = {10.65140/gimn202602.11}
}
EUVIMED